Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 3/20 | 0.64 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.64 |
| ▸ | HRH1 | P35367 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.64 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.64 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.64 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.64 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | HTR2A | P28223 | 2/20 | 0.64 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.64 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.64 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.64 |
| ▸ | ESR1 | P03372 | 1/20 | 0.64 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.64 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.64 |
| ▸ | HRH2 | P25021 | 1/20 | 0.64 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL560996 | 1.00 | CHRM2 (0.64) | CHRM2CHRM1HRH1LMNASLC6A4 | |
| SCHEMBL579694 | 1.00 | CHRM2 (0.64) | CHRM2CHRM1HRH1LMNASLC6A4 | |
| SCHEMBL5098280 | 0.89 | LMNA (0.61) | CHRM2CHRM1HRH1LMNASLC6A4 | |
| Bromide SCHEMBL5676142 | 0.88 | LMNA (0.60) | CHRM2CHRM1HRH1LMNASLC6A4 | |
| SCHEMBL579977 | 0.86 | LMNA (0.47) | CHRM2CHRM1HRH1LMNASLC6A4 | |
| SCHEMBL579985 | 0.86 | LMNA (0.47) | CHRM2CHRM1HRH1LMNASLC6A4 | |
| SCHEMBL580461 | 0.86 | LMNA (0.47) | CHRM2CHRM1HRH1LMNASLC6A4 | |
| SCHEMBL3105500 | 0.86 | SLC6A4 (0.63) | CHRM2CHRM1HRH1LMNASLC6A4 | |
| SCHEMBL3105509 | 0.86 | SLC6A4 (0.63) | CHRM2CHRM1HRH1LMNASLC6A4 | |
| Hydrochloric Acid SCHEMBL5199828 | 0.85 | CYP3A4 (0.48) | CHRM2CHRM1HRH1LMNASLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1434574-A2 | TOLTERODINE METABOLITES | Bridge Pharma, Inc. (US) | 2004-07-07 | — | — | EP | claimed |
| US-20030027856-A1 | Tolterodine metabolites | BRIDGE PHARMA, INC. | 2003-02-06 | — | — | US | claimed |
| WO-2003002059-A2 | TOLTERODINE METABOLITES | BRIDGE PHARMA, INC. (US) | 2003-01-09 | — | — | WO | claimed |
| EP-1633695-B1 | SMOOTH MUSCLE SPASMOLYTIC AGENTS | BRIDGE PHARMA INC (US) | 2012-02-15 | — | — | EP | disclosed |
| EP-1633695-A4 | SMOOTH MUSCLE SPASMOLYTIC AGENTS | BRIDGE PHARMA INC (US) | 2007-12-12 | — | — | EP | disclosed |
| US-7141696-B2 | Smooth muscle spasmolytic agents | BRIDGE PHARMA, INC. (US) | 2006-11-28 | — | — | US | disclosed |
| EP-1633695-A2 | SMOOTH MUSCLE SPASMOLYTIC AGENTS | Bridge Pharma, Inc. (US) | 2006-03-15 | — | — | EP | disclosed |
| WO-2004105692-A2 | SMOOTH MUSCLE SPASMOLYTIC AGENTS | BRIDGE PHARMA, INC. (US) | 2004-12-09 | — | — | WO | disclosed |
| US-20040248987-A1 | Smooth muscle spasmolytic agents | BRIDGE PHARMA, INC. | 2004-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040248987-A1 | Smooth muscle spasmolytic agents | MYLK, TNNC1, MYLK2 | CHRM2 22/4885CHRM1 39/4885HRH1 589/4885 |
| US-20030027856-A1 | Tolterodine metabolites | COMT, ADRB3, THOP1 | CHRM2 42/4885CHRM1 90/4885HRH1 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.